ensifentrine dry powder inhaler (RPL554 DPI) / Merck (MSD) - LARVOL DELTA

Acquisition of Verona by MSD Approved by the High Court of Justice of England and Wales (GlobeNewswire) - "Closing of the Transaction will occur and the Scheme will become effective upon the Court Order being delivered to the Registrar of Companies, which is expected to occur on October 7, 2025, as previously announced."

M&A • Chronic Obstructive Pulmonary Disease • Immunology